182 related articles for article (PubMed ID: 23504257)
21. Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
de Vries NA; Bruggeman SW; Hulsman D; de Vries HI; Zevenhoven J; Buckle T; Hamans BC; Leenders WP; Beijnen JH; van Lohuizen M; Berns AJ; van Tellingen O
Clin Cancer Res; 2010 Jul; 16(13):3431-41. PubMed ID: 20472681
[TBL] [Abstract][Full Text] [Related]
22. Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma.
Pitter KL; Galbán CJ; Galbán S; Tehrani OS; Li F; Charles N; Bradbury MS; Becher OJ; Chenevert TL; Rehemtulla A; Ross BD; Holland EC; Hambardzumyan D
PLoS One; 2011 Jan; 6(1):e14545. PubMed ID: 21267448
[TBL] [Abstract][Full Text] [Related]
23. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
Saito N; Fu J; Zheng S; Yao J; Wang S; Liu DD; Yuan Y; Sulman EP; Lang FF; Colman H; Verhaak RG; Yung WK; Koul D
Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
[TBL] [Abstract][Full Text] [Related]
24. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
25. Molecular classification of glioblastoma based on immunohistochemical expression of EGFR, PDGFRA, NF1, IDH1, p53 and PTEN proteins.
Jankowska S; Lewandowska M; Masztalewicz M; Sagan L; Nowacki P; Urasińska E
Pol J Pathol; 2021; 72(1):1-10. PubMed ID: 34060283
[TBL] [Abstract][Full Text] [Related]
26. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma.
Chen P; Zhao D; Li J; Liang X; Li J; Chang A; Henry VK; Lan Z; Spring DJ; Rao G; Wang YA; DePinho RA
Cancer Cell; 2019 Jun; 35(6):868-884.e6. PubMed ID: 31185211
[TBL] [Abstract][Full Text] [Related]
27. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
Wei Q; Clarke L; Scheidenhelm DK; Qian B; Tong A; Sabha N; Karim Z; Bock NA; Reti R; Swoboda R; Purev E; Lavoie JF; Bajenaru ML; Shannon P; Herlyn D; Kaplan D; Henkelman RM; Gutmann DH; Guha A
Cancer Res; 2006 Aug; 66(15):7429-37. PubMed ID: 16885338
[TBL] [Abstract][Full Text] [Related]
28. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells.
Koga T; Chaim IA; Benitez JA; Markmiller S; Parisian AD; Hevner RF; Turner KM; Hessenauer FM; D'Antonio M; Nguyen ND; Saberi S; Ma J; Miki S; Boyer AD; Ravits J; Frazer KA; Bafna V; Chen CC; Mischel PS; Yeo GW; Furnari FB
Nat Commun; 2020 Jan; 11(1):550. PubMed ID: 31992716
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
31. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.
Pei J; Park IH; Ryu HH; Li SY; Li CH; Lim SH; Wen M; Jang WY; Jung S
Radiat Oncol; 2015 Aug; 10():164. PubMed ID: 26245666
[TBL] [Abstract][Full Text] [Related]
32. A therapeutic cancer vaccine against GL261 murine glioma.
Kindy MS; Yu J; Zhu H; Smith MT; Gattoni-Celli S
J Transl Med; 2016 Jan; 14():1. PubMed ID: 26727970
[TBL] [Abstract][Full Text] [Related]
33. A human brainstem glioma xenograft model enabled for bioluminescence imaging.
Hashizume R; Ozawa T; Dinca EB; Banerjee A; Prados MD; James CD; Gupta N
J Neurooncol; 2010 Jan; 96(2):151-9. PubMed ID: 19585223
[TBL] [Abstract][Full Text] [Related]
34. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
35. Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
Vitucci M; Karpinich NO; Bash RE; Werneke AM; Schmid RS; White KK; McNeill RS; Huff B; Wang S; Van Dyke T; Miller CR
Neuro Oncol; 2013 Oct; 15(10):1317-29. PubMed ID: 23814263
[TBL] [Abstract][Full Text] [Related]
36. Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.
Thomas SL; Schultz CR; Mouzon E; Golembieski WA; El Naili R; Radakrishnan A; Lemke N; Poisson LM; Gutiérrez JA; Cottingham S; Rempel SA
Brain Pathol; 2015 Jul; 25(4):391-400. PubMed ID: 24862407
[TBL] [Abstract][Full Text] [Related]
37. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo.
Chen H; Huang Q; Dong J; Zhai DZ; Wang AD; Lan Q
BMC Cancer; 2008 Jan; 8():29. PubMed ID: 18230152
[TBL] [Abstract][Full Text] [Related]
39. 53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma.
Squatrito M; Vanoli F; Schultz N; Jasin M; Holland EC
Cancer Res; 2012 Oct; 72(20):5250-60. PubMed ID: 22915756
[TBL] [Abstract][Full Text] [Related]
40. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
